Tirzepatide in Brookings, SD
The Midwest faces some of the highest obesity rates in the country, and Brookings is no exception. With South Dakota reporting 33.9% obesity prevalence and 9.7% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to Brookings residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
GLP-1 weight-loss treatment available to eligible patients in Brookings, SD. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
How does this medication work for weight loss?
For many people in Brookings, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to South Dakota residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Brookings address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
What treatment options are available locally?
Suburban life around Brookings comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide addresses the biology behind weight gain by reducing hunger signals and improving metabolic function, so Brookings area residents can break patterns that willpower alone cannot fix. Weight Method prescribes Tirzepatide virtually, with medication delivered to your door.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

